The November 4 annual meeting vote is the key catalyst. If Bergeron wins a majority of board seats, expect a leadership transition and strategic review. If only Kathwari and Sable are replaced, the incumbent majority (including Tsai) would remain, limiting the scope of change. Monitor ISS and Glass Lewis final recommendations and any management response.
Price Chart
Executive Summary
Doug Bergeron, through DGB Investment, Inc., filed additional definitive proxy soliciting materials on October 29, 2026, six days before Ethan Allen's November 4 annual meeting. The filing highlights the undisclosed court sanctions and alleged misconduct of incumbent director Cynthia Ekberg Tsai, who was sanctioned for destroying evidence and found liable for contempt in a prior fraud litigation, and urges shareholders to vote for all five of Bergeron's nominees on the WHITE proxy card. All three leading proxy advisory firms (ISS, Glass Lewis, Egan-Jones) recommend removing Chairman/CEO Farooq Kathwari and Lead Independent Director David Sable, with Glass Lewis and Egan-Jones recommending for all five dissident nominees.
Key Financial Metrics
Key Facts
- Bergeron's group holds approximately 5.2% of Ethan Allen's outstanding common stock.
- Annual meeting is scheduled for November 4, 2026.
- Bergeron is nominating five director candidates for election to the Board.
- Incumbent director Cynthia Ekberg Tsai was sanctioned by a New York court in 2015 for destroying evidence and found liable for civil contempt in a fraud case; she was removed as a director and terminated 'for cause' as CEO of Viropro.
- Tsai chairs the Corporate Governance, Nominations and Sustainability Committee and previously chaired the Audit Committee.
- ISS, Glass Lewis and Egan-Jones all recommend voting against Chairman/CEO Farooq Kathwari and Lead Independent Director David Sable.
- Glass Lewis and Egan-Jones recommend voting for all five Bergeron nominees and withholding from the entire incumbent Board.
- Bergeron has identified Stefanie Tsen Ward as an interim CEO candidate and developed a first 100-day plan.
- The filing references 15 consecutive quarters of year-over-year sales declines.
- The dissident group was formed via an Amended and Restated Group Agreement dated August 27, 2026.
Financial Impact
No specific financial figures in this filing beyond the 5.2% stake and reference to $187.5M in cash and no debt from the prior SC 13D filing.
Risk Factors
- Shareholders may vote only to replace Kathwari and Sable, leaving the incumbent majority in control and limiting change.
- The company has not disclosed its latest financial results ahead of the vote, which the dissident criticizes.
- Tsai's undisclosed record could trigger further governance scrutiny or legal challenges.
- document contains text addressed to automated readers
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| DFAN14A Filing (Primary) | 0000921895-26-002883 |
| Document: 0000921895-26-002883-index-headers.html | 0000921895-26-002883 |
| Document: 0000921895-26-002883-index.html | 0000921895-26-002883 |
| Document: 0000921895-26-002883.txt | 0000921895-26-002883 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 30, 2026 today | DFAN14A | $19.71 | awaiting T+1 | awaiting T+1 | $20.18 (+2.38%) |
Oct 30, 2026 today | DEFA14A | $19.71 | awaiting T+1 | awaiting T+1 | $20.18 (+2.38%) |
Oct 30, 2026 today | Press Release | $19.95 | awaiting T+1 | awaiting T+1 | $20.18 (+1.15%) |
Oct 29, 2026 1d ago | DFAN14A | $19.71 | awaiting T+1 | awaiting T+1 | $20.18 (+2.38%) |
Oct 28, 2026 2d ago | DFAN14A | $20.18 $20.36 | ▲ +0.89% | ▲ +2.66% | $20.18 (+0.00%) |
Oct 27, 2026 3d ago | DEFA14A | $19.40 $20.18 | ▲ +4.02% | ▲ +4.40% | $20.18 (+4.02%) |
Oct 27, 2026 3d ago | DFAN14A | $19.40 $20.18 | ▲ +4.02% | ▲ +4.40% | $20.18 (+4.02%) |
Oct 27, 2026 3d ago | Press Release | $19.92 $19.40 | ▼ −2.61% | ▼ −2.95% | $20.18 (+1.31%) |
Oct 26, 2026 4d ago | DFAN14A | $19.92 $19.40 | ▼ −2.61% | ▼ −2.95% | $20.18 (+1.31%) |
Oct 22, 2026 8d ago | DFAN14A | $20.45 $20.08 | ▼ −1.81% | ▼ −2.52% | $20.18 (−1.32%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers